ArticleNature communications2018

Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer.

Feng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.